Literature DB >> 181557

Studies on tolerance development to single doses of morphine in mice.

F Huidobro, J P Huidobro-Toro, E Leong Way.   

Abstract

Single-dose tolerance to the antinociceptive effect of morphine can be demonstrated using an adequate initial priming dose of morphine and allowing an interval of 48 to 72 hours for its development. The threshold dose necessary to produce tolerance was found to be about 3 to 4 times greater than that for producing analgesia but higher doses of morphine did not enhance further tolerance development. Evidence of tolerance was indicated by the fact that when the antinociceptive response to morphine was assessed by the hot-plate and the tail-flick procedures, a shift in the dose-response curve of morphine to the right occurred after an adequate single priming dose of morphine. Cross-tolerance was evidenced by a decrease in analgetic response to methadone 3 days after a single priming dose of morphine and a decrease in morphine response after a single dose of methadone. The development of single-dose tolerance was inhibited by cycloheximide. Single-dose tolerance was also blocked by 5,6-dihydroxytryptamine and perhaps enhanced by L-tryptophan. Cyclic 3',5'-adensine monophosphate did not affect single-dose tolerance development significantly although the direction was in favor of augmentation. Morphine uptake by the brain was not modified by the development of single-dose tolerance. Physical dependence, as measured by naloxone-precipitated withdrawal jumping, was not observed when single-dose analgetic tolerance was maximal. The results suggest that single-dose tolerance to morphine involves the synthesis of some macromolecule and support previous findings in this laboratroy involving an association with serotonin.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 181557

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

1.  Single-dose tolerance to the behavioral effects of dibutyryl cyclic AMP in mice.

Authors:  M Weiner; J W Olson
Journal:  Psychopharmacology (Berl)       Date:  1977-08-31       Impact factor: 4.530

Review 2.  Effector antagonism by the regulators of G protein signalling (RGS) proteins causes desensitization of mu-opioid receptors in the CNS.

Authors:  Javier Garzón; María Rodríguez-Muñoz; Elena de la Torre-Madrid; Pilar Sánchez-Blázquez
Journal:  Psychopharmacology (Berl)       Date:  2005-04-14       Impact factor: 4.530

3.  An electromyographic method for the assessment of naloxone-induced abstinence in morphine-dependent rats.

Authors:  M K Menon; L F Tseng; H H Loh; W G Clark
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-05       Impact factor: 3.000

4.  Development and disappearance of subsensitivity to pilocarpine following a single administration of the irreversible anticholinesterase angent, DFP.

Authors:  D H Overstreet; S C Helps; A M Prescott; G D Schiller
Journal:  Psychopharmacology (Berl)       Date:  1977-05-09       Impact factor: 4.530

5.  Morphine-induced anorexia in lateral hypothalamic rats.

Authors:  M Leshem
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

Review 6.  Nitric oxide and zinc-mediated protein assemblies involved in mu opioid receptor signaling.

Authors:  María Rodríguez-Muñoz; Javier Garzón
Journal:  Mol Neurobiol       Date:  2013-05-11       Impact factor: 5.590

7.  Antidiuretic effect of morphine in the rat: tolerance and physical dependence.

Authors:  F Huidobro
Journal:  Br J Pharmacol       Date:  1978-10       Impact factor: 8.739

Review 8.  Synthesis of the Mechanisms of Opioid Tolerance: Do We Still Say NO?

Authors:  Laura J Gledhill; Anna-Marie Babey
Journal:  Cell Mol Neurobiol       Date:  2021-03-11       Impact factor: 5.046

Review 9.  Opioid receptor desensitization: mechanisms and its link to tolerance.

Authors:  Stéphane Allouche; Florence Noble; Nicolas Marie
Journal:  Front Pharmacol       Date:  2014-12-18       Impact factor: 5.810

10.  Morphine induces endocytosis of neuronal mu-opioid receptors through the sustained transfer of Galpha subunits to RGSZ2 proteins.

Authors:  María Rodríguez-Muñoz; Elena de la Torre-Madrid; Pilar Sánchez-Blázquez; Javier Garzón
Journal:  Mol Pain       Date:  2007-07-17       Impact factor: 3.395

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.